Anti-LCN2 antibody treatment is associated with attenuated hearing loss and blood–labyrinth barrier disruption in a mouse model of chronic kidney disease
- DOI
- 10.1007/s10735-026-10963-4
- Published
- 2026-08-30
- Container
- Journal of Molecular Histology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10735-026-10963-4,
title = {Anti-LCN2 antibody treatment is associated with attenuated hearing loss and blood–labyrinth barrier disruption in a mouse model of chronic kidney disease},
author = {Ye Ding and Xin Jiang and Xiangming Ye},
year = {2026},
journal = {Journal of Molecular Histology},
doi = {10.1007/s10735-026-10963-4},
url = {https://doi.org/10.1007/s10735-026-10963-4}
}RIS
TY - JOUR TI - Anti-LCN2 antibody treatment is associated with attenuated hearing loss and blood–labyrinth barrier disruption in a mouse model of chronic kidney disease AU - Ye Ding AU - Xin Jiang AU - Xiangming Ye PY - 2026 JO - Journal of Molecular Histology DO - 10.1007/s10735-026-10963-4 UR - https://doi.org/10.1007/s10735-026-10963-4 ER -
APA
Ding, Y., Jiang, X., & Ye, X. (2026). Anti-LCN2 antibody treatment is associated with attenuated hearing loss and blood–labyrinth barrier disruption in a mouse model of chronic kidney disease. Journal of Molecular Histology. https://doi.org/10.1007/s10735-026-10963-4
Source records
- crossref · retrieved 2026-09-26T19:41:15.474Z